Axon Enterprise, Inc. R&D decreased by 2.6% to $188.95M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.1%, from $151.02M to $188.95M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 37.0% CAGR.
Analysis
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_developmentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $53.95M | $42.38M | $50.67M | $48.42M | $57.55M | $59.13M | $68.72M | $70.93M | $71.94M | $76.88M | $83.97M | $91.10M | $101.43M | $114.48M | $134.59M | $151.02M | $162.57M | $176.67M | $194.04M | $188.95M |
| QoQ Change | — | -21.4% | +19.6% | -4.5% | +18.9% | +2.7% | +16.2% | +3.2% | +1.4% | +6.9% | +9.2% | +8.5% | +11.3% | +12.9% | +17.6% | +12.2% | +7.6% | +8.7% | +9.8% | -2.6% |
| YoY Change | — | — | — | — | +6.7% | +39.5% | +35.6% | +46.5% | +25.0% | +30.0% | +22.2% | +28.4% | +41.0% | +48.9% | +60.3% | +65.8% | +60.3% | +54.3% | +44.2% | +25.1% |
Business Segments — Software And Sensors
| Segment | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|
| Software And Sensors | $38.52M | $44.23M | $45.26M | $54.19M | $54.85M | $57.56M | $61.21M | $67.71M |
| Taser | $9.90M | $13.32M | $13.86M | $14.53M | $16.08M | $14.38M | $15.67M | $16.27M |
| Total | $48.42M | $57.55M | $59.13M | $68.72M | $70.93M | $71.94M | $76.88M | $83.97M |
Software And Sensors, Taser were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Business Segments — Softwareand Sensors
| Segment | Q1 '22 | Q2 '22 | Q3 '22 |
|---|---|---|---|
| Softwareand Sensors | $38.52M | $44.23M | $45.26M |
| Total | $48.42M | $57.55M | $59.13M |
Softwareand Sensors was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
R&D at Other Companies
Frequently Asked Questions
- What is Axon Enterprise, Inc.'s r&d?
- Axon Enterprise, Inc. (AAXN) reported r&d of $188.95M in Q1 2026.
- How has Axon Enterprise, Inc.'s r&d changed year-over-year?
- Axon Enterprise, Inc.'s r&d increased by 25.1% year-over-year, from $151.02M to $188.95M.
- What is the long-term trend for Axon Enterprise, Inc.'s r&d?
- Over 4 years (2021 to 2025), Axon Enterprise, Inc.'s r&d has grown at a 37.0% compound annual growth rate (CAGR), from $194.03M to $684.31M.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.